Loading…

Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist

IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) 2004-08, Vol.173 (3), p.1681-1688
Main Authors: Mortier, Erwan, Bernard, Jérôme, Plet, Ariane, Jacques, Yannick
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3
cites cdi_FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3
container_end_page 1688
container_issue 3
container_start_page 1681
container_title The Journal of immunology (1950)
container_volume 173
creator Mortier, Erwan
Bernard, Jérôme
Plet, Ariane
Jacques, Yannick
description IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL-15 appears to be crucial for the function of the innate immune responses, and the pleiotropic expression of IL-15 and IL-15R alpha hints at a much broader role for the IL-15 system in multiple cell types and tissues. In this report, using a highly sensitive radioimmunoassay, we show the existence of a soluble form of human IL-15R alpha (sIL-15R alpha) that arises from proteolytic shedding of the membrane-anchored receptor. This soluble receptor is spontaneously released from IL-15R alpha-expressing human cell lines as well as from IL-15R alpha transfected COS-7 cells. This release is strongly induced by PMA and ionomycin, and to a lesser extent by IL-1 beta and TNF-alpha. The size of sIL-15R alpha (42 kDa), together with the analysis of deletion mutants in the ectodomain of IL-15R alpha, indicates the existence of cleavage sites that are proximal to the plasma membrane. Whereas shedding induced by PMA was abrogated by the synthetic matrix metalloproteinases inhibitor GM6001, the spontaneous shedding was not, indicating the occurrence of at least two distinct proteolytic mechanisms. The sIL-15R alpha displayed high affinity for IL-15 and behaved as a potent and specific inhibitor of IL-15 binding to the membrane receptor, and of IL-15-induced cell proliferation (IC(50) in the range from 3 to 20 pM). These results suggest that IL-15R alpha shedding may play important immunoregulatory functions.
doi_str_mv 10.4049/jimmunol.173.3.1681
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18018832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18018832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3</originalsourceid><addsrcrecordid>eNpFkc9q3DAQh0VpaTZpn6BQdOop3kiW9cfHEpo0sLSX9izG8ihWkC3Xkgv7EHnnesmWnGYYfvPBzEfIJ872DWvam6cwjuuU4p5rsRd7rgx_Q3ZcSlYpxdRbsmOsriuulb4glzk_McYUq5v35ILLWknT6h15_gFlXSBe03lJBVM8luDoghEhI02eAs0prl1E6tMynibDOsJEHw4Vl1vQ4VzSQiHOA1RugDDRMkChHQ7wFzOFfELM6IIP7poO4XGg4H2YQjmeITAVeExTyOUDeechZvx4rlfk9923X7ffq8PP-4fbr4fKCa1LJdG3ruPM-LavRWu4wla1wJjskMlG1Y3vJDO9aOTW9LzzummN1sZ51bi-E1fkywt3O_rPirnYMWSHMcKEac2WG8aNEfUWFC9Bt6ScF_R2XsIIy9FyZk8W7H8LdrNghT1Z2LY-n_FrN2L_unN-u_gHSKyGTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18018832</pqid></control><display><type>article</type><title>Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>Mortier, Erwan ; Bernard, Jérôme ; Plet, Ariane ; Jacques, Yannick</creator><creatorcontrib>Mortier, Erwan ; Bernard, Jérôme ; Plet, Ariane ; Jacques, Yannick</creatorcontrib><description>IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL-15 appears to be crucial for the function of the innate immune responses, and the pleiotropic expression of IL-15 and IL-15R alpha hints at a much broader role for the IL-15 system in multiple cell types and tissues. In this report, using a highly sensitive radioimmunoassay, we show the existence of a soluble form of human IL-15R alpha (sIL-15R alpha) that arises from proteolytic shedding of the membrane-anchored receptor. This soluble receptor is spontaneously released from IL-15R alpha-expressing human cell lines as well as from IL-15R alpha transfected COS-7 cells. This release is strongly induced by PMA and ionomycin, and to a lesser extent by IL-1 beta and TNF-alpha. The size of sIL-15R alpha (42 kDa), together with the analysis of deletion mutants in the ectodomain of IL-15R alpha, indicates the existence of cleavage sites that are proximal to the plasma membrane. Whereas shedding induced by PMA was abrogated by the synthetic matrix metalloproteinases inhibitor GM6001, the spontaneous shedding was not, indicating the occurrence of at least two distinct proteolytic mechanisms. The sIL-15R alpha displayed high affinity for IL-15 and behaved as a potent and specific inhibitor of IL-15 binding to the membrane receptor, and of IL-15-induced cell proliferation (IC(50) in the range from 3 to 20 pM). These results suggest that IL-15R alpha shedding may play important immunoregulatory functions.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.173.3.1681</identifier><identifier>PMID: 15265897</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Cell Division - drug effects ; Cell Line, Tumor - drug effects ; Cell Line, Tumor - metabolism ; Cercopithecus aethiops ; COS Cells ; Culture Media, Conditioned - analysis ; Dipeptides - pharmacology ; DNA, Complementary - genetics ; Glioblastoma - pathology ; Glycosylphosphatidylinositols - metabolism ; Humans ; Interleukin-1 - pharmacology ; Interleukin-15 - antagonists &amp; inhibitors ; Interleukin-15 - pharmacology ; Ionomycin - pharmacology ; Lymphoma, T-Cell - pathology ; Molecular Weight ; Protease Inhibitors - pharmacology ; Protein Binding - drug effects ; Protein Subunits ; Receptors, Interleukin-15 ; Receptors, Interleukin-2 - chemistry ; Receptors, Interleukin-2 - genetics ; Receptors, Interleukin-2 - physiology ; Solubility ; Tetradecanoylphorbol Acetate - pharmacology ; Transfection ; Tumor Necrosis Factor-alpha - pharmacology ; U937 Cells - drug effects ; U937 Cells - metabolism</subject><ispartof>The Journal of immunology (1950), 2004-08, Vol.173 (3), p.1681-1688</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3</citedby><cites>FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15265897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mortier, Erwan</creatorcontrib><creatorcontrib>Bernard, Jérôme</creatorcontrib><creatorcontrib>Plet, Ariane</creatorcontrib><creatorcontrib>Jacques, Yannick</creatorcontrib><title>Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL-15 appears to be crucial for the function of the innate immune responses, and the pleiotropic expression of IL-15 and IL-15R alpha hints at a much broader role for the IL-15 system in multiple cell types and tissues. In this report, using a highly sensitive radioimmunoassay, we show the existence of a soluble form of human IL-15R alpha (sIL-15R alpha) that arises from proteolytic shedding of the membrane-anchored receptor. This soluble receptor is spontaneously released from IL-15R alpha-expressing human cell lines as well as from IL-15R alpha transfected COS-7 cells. This release is strongly induced by PMA and ionomycin, and to a lesser extent by IL-1 beta and TNF-alpha. The size of sIL-15R alpha (42 kDa), together with the analysis of deletion mutants in the ectodomain of IL-15R alpha, indicates the existence of cleavage sites that are proximal to the plasma membrane. Whereas shedding induced by PMA was abrogated by the synthetic matrix metalloproteinases inhibitor GM6001, the spontaneous shedding was not, indicating the occurrence of at least two distinct proteolytic mechanisms. The sIL-15R alpha displayed high affinity for IL-15 and behaved as a potent and specific inhibitor of IL-15 binding to the membrane receptor, and of IL-15-induced cell proliferation (IC(50) in the range from 3 to 20 pM). These results suggest that IL-15R alpha shedding may play important immunoregulatory functions.</description><subject>Animals</subject><subject>Cell Division - drug effects</subject><subject>Cell Line, Tumor - drug effects</subject><subject>Cell Line, Tumor - metabolism</subject><subject>Cercopithecus aethiops</subject><subject>COS Cells</subject><subject>Culture Media, Conditioned - analysis</subject><subject>Dipeptides - pharmacology</subject><subject>DNA, Complementary - genetics</subject><subject>Glioblastoma - pathology</subject><subject>Glycosylphosphatidylinositols - metabolism</subject><subject>Humans</subject><subject>Interleukin-1 - pharmacology</subject><subject>Interleukin-15 - antagonists &amp; inhibitors</subject><subject>Interleukin-15 - pharmacology</subject><subject>Ionomycin - pharmacology</subject><subject>Lymphoma, T-Cell - pathology</subject><subject>Molecular Weight</subject><subject>Protease Inhibitors - pharmacology</subject><subject>Protein Binding - drug effects</subject><subject>Protein Subunits</subject><subject>Receptors, Interleukin-15</subject><subject>Receptors, Interleukin-2 - chemistry</subject><subject>Receptors, Interleukin-2 - genetics</subject><subject>Receptors, Interleukin-2 - physiology</subject><subject>Solubility</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Transfection</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>U937 Cells - drug effects</subject><subject>U937 Cells - metabolism</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpFkc9q3DAQh0VpaTZpn6BQdOop3kiW9cfHEpo0sLSX9izG8ihWkC3Xkgv7EHnnesmWnGYYfvPBzEfIJ872DWvam6cwjuuU4p5rsRd7rgx_Q3ZcSlYpxdRbsmOsriuulb4glzk_McYUq5v35ILLWknT6h15_gFlXSBe03lJBVM8luDoghEhI02eAs0prl1E6tMynibDOsJEHw4Vl1vQ4VzSQiHOA1RugDDRMkChHQ7wFzOFfELM6IIP7poO4XGg4H2YQjmeITAVeExTyOUDeechZvx4rlfk9923X7ffq8PP-4fbr4fKCa1LJdG3ruPM-LavRWu4wla1wJjskMlG1Y3vJDO9aOTW9LzzummN1sZ51bi-E1fkywt3O_rPirnYMWSHMcKEac2WG8aNEfUWFC9Bt6ScF_R2XsIIy9FyZk8W7H8LdrNghT1Z2LY-n_FrN2L_unN-u_gHSKyGTA</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Mortier, Erwan</creator><creator>Bernard, Jérôme</creator><creator>Plet, Ariane</creator><creator>Jacques, Yannick</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20040801</creationdate><title>Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist</title><author>Mortier, Erwan ; Bernard, Jérôme ; Plet, Ariane ; Jacques, Yannick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Cell Division - drug effects</topic><topic>Cell Line, Tumor - drug effects</topic><topic>Cell Line, Tumor - metabolism</topic><topic>Cercopithecus aethiops</topic><topic>COS Cells</topic><topic>Culture Media, Conditioned - analysis</topic><topic>Dipeptides - pharmacology</topic><topic>DNA, Complementary - genetics</topic><topic>Glioblastoma - pathology</topic><topic>Glycosylphosphatidylinositols - metabolism</topic><topic>Humans</topic><topic>Interleukin-1 - pharmacology</topic><topic>Interleukin-15 - antagonists &amp; inhibitors</topic><topic>Interleukin-15 - pharmacology</topic><topic>Ionomycin - pharmacology</topic><topic>Lymphoma, T-Cell - pathology</topic><topic>Molecular Weight</topic><topic>Protease Inhibitors - pharmacology</topic><topic>Protein Binding - drug effects</topic><topic>Protein Subunits</topic><topic>Receptors, Interleukin-15</topic><topic>Receptors, Interleukin-2 - chemistry</topic><topic>Receptors, Interleukin-2 - genetics</topic><topic>Receptors, Interleukin-2 - physiology</topic><topic>Solubility</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Transfection</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>U937 Cells - drug effects</topic><topic>U937 Cells - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mortier, Erwan</creatorcontrib><creatorcontrib>Bernard, Jérôme</creatorcontrib><creatorcontrib>Plet, Ariane</creatorcontrib><creatorcontrib>Jacques, Yannick</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mortier, Erwan</au><au>Bernard, Jérôme</au><au>Plet, Ariane</au><au>Jacques, Yannick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>173</volume><issue>3</issue><spage>1681</spage><epage>1688</epage><pages>1681-1688</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>IL-15 and IL-2 are two structurally and functionally related cytokines whose high affinity receptors share the IL-2R beta-chain and gamma-chain in association with IL-15R alpha-chain (IL-15R alpha) or IL-2R alpha-chain, respectively. Whereas IL-2 action seems restricted to the adaptative T cells, IL-15 appears to be crucial for the function of the innate immune responses, and the pleiotropic expression of IL-15 and IL-15R alpha hints at a much broader role for the IL-15 system in multiple cell types and tissues. In this report, using a highly sensitive radioimmunoassay, we show the existence of a soluble form of human IL-15R alpha (sIL-15R alpha) that arises from proteolytic shedding of the membrane-anchored receptor. This soluble receptor is spontaneously released from IL-15R alpha-expressing human cell lines as well as from IL-15R alpha transfected COS-7 cells. This release is strongly induced by PMA and ionomycin, and to a lesser extent by IL-1 beta and TNF-alpha. The size of sIL-15R alpha (42 kDa), together with the analysis of deletion mutants in the ectodomain of IL-15R alpha, indicates the existence of cleavage sites that are proximal to the plasma membrane. Whereas shedding induced by PMA was abrogated by the synthetic matrix metalloproteinases inhibitor GM6001, the spontaneous shedding was not, indicating the occurrence of at least two distinct proteolytic mechanisms. The sIL-15R alpha displayed high affinity for IL-15 and behaved as a potent and specific inhibitor of IL-15 binding to the membrane receptor, and of IL-15-induced cell proliferation (IC(50) in the range from 3 to 20 pM). These results suggest that IL-15R alpha shedding may play important immunoregulatory functions.</abstract><cop>United States</cop><pmid>15265897</pmid><doi>10.4049/jimmunol.173.3.1681</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 2004-08, Vol.173 (3), p.1681-1688
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_18018832
source Free E-Journal (出版社公開部分のみ)
subjects Animals
Cell Division - drug effects
Cell Line, Tumor - drug effects
Cell Line, Tumor - metabolism
Cercopithecus aethiops
COS Cells
Culture Media, Conditioned - analysis
Dipeptides - pharmacology
DNA, Complementary - genetics
Glioblastoma - pathology
Glycosylphosphatidylinositols - metabolism
Humans
Interleukin-1 - pharmacology
Interleukin-15 - antagonists & inhibitors
Interleukin-15 - pharmacology
Ionomycin - pharmacology
Lymphoma, T-Cell - pathology
Molecular Weight
Protease Inhibitors - pharmacology
Protein Binding - drug effects
Protein Subunits
Receptors, Interleukin-15
Receptors, Interleukin-2 - chemistry
Receptors, Interleukin-2 - genetics
Receptors, Interleukin-2 - physiology
Solubility
Tetradecanoylphorbol Acetate - pharmacology
Transfection
Tumor Necrosis Factor-alpha - pharmacology
U937 Cells - drug effects
U937 Cells - metabolism
title Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A49%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Natural,%20proteolytic%20release%20of%20a%20soluble%20form%20of%20human%20IL-15%20receptor%20alpha-chain%20that%20behaves%20as%20a%20specific,%20high%20affinity%20IL-15%20antagonist&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Mortier,%20Erwan&rft.date=2004-08-01&rft.volume=173&rft.issue=3&rft.spage=1681&rft.epage=1688&rft.pages=1681-1688&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.173.3.1681&rft_dat=%3Cproquest_cross%3E18018832%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c377t-5ef9cb108f9d239816e969a005be054624fb508d345fb5d1bf7498778cf64cdb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18018832&rft_id=info:pmid/15265897&rfr_iscdi=true